JP Morgan Maintains Overweight on Nuvalent, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anupam Rama has maintained an Overweight rating on Nuvalent (NASDAQ:NUVL) and increased the price target from $90 to $100.
September 04, 2024 | 10:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan has reaffirmed its Overweight rating on Nuvalent and increased the price target to $100, indicating confidence in the company's future performance.
The increase in price target from $90 to $100 by JP Morgan suggests a positive outlook on Nuvalent's future performance. The Overweight rating indicates that the analyst expects the stock to outperform its peers. This is likely to have a positive short-term impact on the stock price as investors may view this as a strong endorsement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100